Top compounds associated with response to TMEM108


Feature Type Standardized
Nominal ANOVA
mRNA Vinorelbine GDSC1000 pan-cancer AAC -0.19 3e-06
mRNA AZD6482 GDSC1000 pan-cancer AAC -0.17 4e-06
mRNA RO-3306 GDSC1000 pan-cancer AAC -0.19 8e-06
mRNA BRD8899 CTRPv2 pan-cancer AAC 0.21 1e-05
mRNA FH535 GDSC1000 pan-cancer AAC -0.18 1e-05
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 1e-05
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 2e-05
mRNA NVP-BEZ235 GDSC1000 pan-cancer AAC -0.18 2e-05
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC -0.17 3e-05
mRNA Tipifarnib GDSC1000 pan-cancer AAC -0.17 3e-05
Download CSV